The Cooper (NYSE:COO) Cash-to-Debt

: 0.04 (As of Jan. 2023)

View and export this data going back to 1983. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. The Cooper's cash to debt ratio for the quarter that ended in Jan. 2023 was 0.04.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, The Cooper couldn't pay off its debt using the cash in hand for the quarter that ended in Jan. 2023.

The historical rank and industry rank for The Cooper's Cash-to-Debt or its related term are showing as below:

COO' s Cash-to-Debt Range Over the Past 10 Years
Min: 0 Med: 0.07 Max: 2.39
Current: 0.04

During the past 13 years, The Cooper's highest Cash to Debt Ratio was 2.39. The lowest was 0.00. And the median was 0.07.

COO's Cash-to-Debt is ranked worse than
95.57% of 857 companies
in the Medical Devices & Instruments industry
Industry Median: 2.69 vs COO: 0.04

The Cooper Cash-to-Debt Historical Data

The historical data trend for The Cooper's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Cash-to-Debt

0.04

0.05

0.06

0.07

0.05

The Cooper Quarterly Data
	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23
Cash-to-Debt																0.08	0.11	0.08	0.05	0.04

Competitive Comparison

For the Medical Instruments & Supplies subindustry, The Cooper's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

The Cooper Cash-to-Debt Distribution

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where The Cooper's Cash-to-Debt falls in comparison to its industry or sector. The grey bar indicates the Cash-to-Debt's extreme value range as defined by GuruFocus.

The Cooper Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

The Cooper's Cash to Debt Ratio for the fiscal year that ended in Oct. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	138.2	/	(412.6	+	2350.8)
	=	0.05

The Cooper's Cash to Debt Ratio for the quarter that ended in Jan. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	118.2	/	(68.1	+	2627.3)
	=	0.04

The Cooper (NYSE:COO) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

The Cooper Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of The Cooper's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

The Cooper (NYSE:COO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (NYSE:COO) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

CP6:Germany C1OO34:Brazil

Address

6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583

Website

https://www.coopercos.com

Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for approximately 75% of total sales, CooperVision is the the second-largest player in the oligopolistic contact lens market. Over 50% of CooperVision's sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017.

Executives

Cynthia L Lucchese	director	7966 N. ILLINOIS STREET, INDIANAPOLIS IN 46260
Nicholas Khadder	officer: VP, General Counsel & Corp Sec	2836 JOHNSON AVENUE, ALAMEDA CA 94501
Warner Gerard H Iii	officer: President, CooperVision, Inc.	C/O COOPER COMPANIES INC., 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON CA 94583
Maria Rivas	director	C/O MEDIDATA SOLUTIONS, INC., 350 HUDSON STREET, 9TH FLOOR, NEW YORK NY 10014
Teresa S Madden	director	414 NICOLLET MALL, MINNEAPOLIS MN 55401
Mark J Drury	officer: VP, General Counsel & Sec.	C/O COOPERCOMPANIES, 6101 BOLLINGER CANYON ROAD, SUITE 500, SAN RAMON CA 94583
Robert D Auerbach	officer: President, CSI	C/O THE COOPER COMPANIES, INC., SUITE 590, PLEASANTON CA 94588
Holly R Sheffield	officer: EVP, CSO	C/O THE COOPER COMPANIES, INC., 6140 STONERIDGE MALL ROAD, SUITE 590, PLEASANTON CA 94588
Agostino Ricupati	officer: Sr. VP, Finance & Tax	C/O THE COOPER COMPANIES, INC., 6140 STONERIDGE MALL ROAD, SUITE 590, PLEASANTON CA 94588
William A Kozy	director	C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Jay Colleen	director	C/O THE COOPER COMPANIES, INC., 6140 STONERIDGE MALL ROAD, SUITE 590, PLEASANTON CA 94588
Randal Golden	officer: General Counsel	6140 STONERIDGE MALL ROAD, SUITE 590, PLEASANTON CA 94588
Tina Maloney	officer: Corporate Controller	6140 STONERIDGE MALL ROAD, SUITE 590, PLEASANTON CA 94588
Gary S Petersmeyer	director	3400 CENTRAL AVENUE, SANTA CLARA CA 95051
Brian G Andrews	officer: Treasurer	4300A 17TH STREET, SAN FRANCISCO CA 94114